FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Etoposide Injection
Status: Resolved
»Duration of Shortage: 01/24/2018 - 06/12/2019
»Therapeutic Categories: Oncology

Expand all

Accord Healthcare Inc. (Revised 06/12/2019)

Company Contact Information:
866-941-7875

Presentation
  • ETOPOSIDE INJ USP 20MG/ML 5ML (NDC 16729-114-31)
  • ETOPOSIDE INJ USP 20MG/ML (Nova Plus) 5ML (NDC 16729-262-31)
  • ETOPOSIDE INJ. USP 20MG/ML 25 ML (NDC 16729-114-08)
  • ETOPOSIDE INJ. USP 20MG/ML 50 ML (NDC 16729-114-11)
Note:
  • N/A

Fresenius Kabi USA, LLC (Revised 06/12/2019)

Company Contact Information:
888-386-1300

Presentation
  • 100 mg per 5 mL, 20 mg per mL, MDV (NDC 63323-104-05)
  • 500 mg per 25 mL, 20 mg per mL, MDV (NDC 63323-104-25)
  • 1 gram per 50 mL, 20 mg per mL, MDV (NDC 63323-104-50)
Note:
  • N/A

West-Ward Pharmaceuticals (Revised 06/12/2019)

Company Contact Information:
800-631-2174

Presentation
  • 20 mg/mL, 5 mL vial (NDC 0143-9510-01)
  • 20 mg/mL, 25 mL vial (NDC 0143-9511-01)
  • 20 mg/mL, 50 mL vial (NDC 0143-9512-01)
Note:
  • N/A

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English